search
Novartis
Trends
- 1Novartis signs $7.8 billion mRNA deal with China's Abogen●Novartis strikes about $7.8 billion mRNA deal with China's Abogen
Swiss drugmaker Novartis has agreed a deal worth about $7.8 billion with China's Abogen Biosciences, according to Reuters. The agreement centres on mRNA technology, marking a significant move by Novartis into the field and a landmark licensing arrangement for a Chinese biotech firm with a major Western pharmaceutical partner.
- 2
Novartis is highlighting the role of faith communities in community health, under the message that community health takes a village, 'from pulpit to pew'. The initiative points to churches and congregations as trusted venues for health outreach and education. Reactions beyond the company's own messaging are not yet visible, and no details about specific programmes or partners have been reported.